NYSE:LLY - Eli Lilly And Co Stock Price, Forecast & News

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co declared a quarterly dividend on Monday, December 16th. Investors of record on Friday, February 14th will be paid a dividend of $0.74 per share on Tuesday, March 10th. This represents a $2.96 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date is Thursday, February 13th. This is a boost from Eli Lilly And Co's previous quarterly dividend of $0.65. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) issued its quarterly earnings data on Thursday, January, 30th. The company reported $1.73 EPS for the quarter, beating the Zacks' consensus estimate of $1.52 by $0.21. The company earned $6.11 billion during the quarter, compared to analyst estimates of $5.92 billion. Eli Lilly And Co's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.33 EPS. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co issued an update on its FY20 earnings guidance on Thursday, January, 30th. The company provided EPS guidance of $6.70-6.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.76. The company issued revenue guidance of $23.7-24.2 billion, compared to the consensus revenue estimate of $23.78 billion.

14 equities research analysts have issued 12-month price objectives for Eli Lilly And Co's stock. Their forecasts range from $117.49 to $165.00. On average, they expect Eli Lilly And Co's stock price to reach $137.95 in the next year. This suggests that the stock has a possible downside of 2.2%. View Analyst Price Targets for Eli Lilly And Co.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

Media stories about LLY stock have trended neutral on Sunday, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Eli Lilly And Co earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a increase in short interest in January. As of January 31st, there was short interest totalling 12,980,000 shares, an increase of 14.8% from the January 15th total of 11,310,000 shares. Based on an average daily trading volume, of 3,450,000 shares, the short-interest ratio is currently 3.8 days. Currently, 1.5% of the shares of the company are sold short. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include AbbVie (ABBV), The Medicines (MDCO), Assembly Biosciences (ASMB), Ampio Pharmaceuticals (AMPE), Melinta Therapeutics (MLNT), Acura Pharmaceuticals (ACUR), Akorn (AKRX), Allergan (AGN), BioDelivery Sciences International (BDSI), Bristol-Myers Squibb (BMY), Corcept Therapeutics (CORT), Cumberland Pharmaceuticals (CPIX), Endo International (ENDP), Horizon Therapeutics (HZNP) and Jazz Pharmaceuticals (JAZZ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AT&T (T), Intel (INTC), Verizon Communications (VZ), JPMorgan Chase & Co. (JPM), Bristol-Myers Squibb (BMY), Bank of America (BAC) and Cisco Systems (CSCO).

Eli Lilly And Co's stock is owned by a number of of retail and institutional investors. Top institutional investors include Lilly Endowment Inc. (11.93%), State Street Corp (3.87%), FMR LLC (1.48%), Bank of New York Mellon Corp (0.85%), Franklin Resources Inc. (0.79%) and Massachusetts Financial Services Co. MA (0.63%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, Daniel Skovronsky, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Lilly Endowment Inc., Investec Asset Management LTD, LSV Asset Management, Assenagon Asset Management S.A., Massachusetts Financial Services Co. MA, AQR Capital Management LLC, Great West Life Assurance Co. Can and DekaBank Deutsche Girozentrale. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, FMR LLC, Amundi Pioneer Asset Management Inc., Franklin Resources Inc., CI Investments Inc., PGGM Investments, Robeco Institutional Asset Management B.V. and Prudential Financial Inc.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Anne E White, Daniel Skovronsky, David A Ricks, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $141.12.